Bellerophon Therapeutics, Inc. 4
4 · Bellerophon Therapeutics, Inc. · Filed Jun 21, 2016
Insider Transaction Report
Form 4
Holt Matthew S.
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2016-06-17+10,000→ 10,000 totalExercise: $1.94Exp: 2026-06-16→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 17, 2016. This option vests in three equal annual installments over a three-year period from the date of grant.